| Autor: |
Hanif M; Department of Pharmacy, Bahauddin Zakariya University, Multan, Pakistan., Qureshi J; Department of Pharmacy, Bahauddin Zakariya University, Multan, Pakistan., Ijaz H; Faculty of Pharmacy, University of Sargodha, Sargodha, Pakistan., Mustafa MI; Institute of Dairy Sciences, University of Agriculture, Faisalabad, Pakistan., Rasul A; Faculty of Pharmacy, Government College University Faisalabad, Pakistan., Amir N; Faculty of Pharmacy, Government College University Faisalabad, Pakistan., Aftab B; Department of Pharmacy, Bahauddin Zakariya University, Multan, Pakistan., Fayyaz A; Department of Pathology, University of Agriculture, Faisalabad, Pakistan. |
| Abstrakt: |
COPD is a complicated disease. Current available treatments are just for symptomatic relief and they cannot reverse the damages to lungs tissues due to alveolar destruction in COPD. Research is being conducted to evaluate new treatments and strategies to find specific treatments to minimize the symptoms of COPD. A new mixture of herbal medicine i.e AKL1 has emerged and thought to cure COPD symptoms especially cough related quality of life of COPD patients. Although, the results have showed no significant difference as compared to placebo but researchers recommend further evaluation in a large population (COPD Patients) group. Another medicine Roflumilast, a phosphodiesterase 4 inhibitor, was also found to be effective to treat COPD under specific recommendations with further research needed. Finally another medicine Indacaterol, a novel, once-daily (o.d) inhaled long-acting β2-agonist proved to be effective clinically to treat COPD related broncho-constriction and also increasing the COPD patient's compliance by reducing the number of doses as compared to other conventional inhaled bronchodilators such as Albuterol. |
